Is fibrinogen concentrate useful for bleeding in high-risk cardiac surgery? In a study conducted in The Netherlands, [1] 647 patients (from 2011 to 2015) scheduled to have high-risk cardiac surgery ...
Fesilty is expected to be available in the first half of 2026. The Food and Drug Administration (FDA) has approved Fesilty ™ (fibrinogen, human-chmt) for the treatment of acute bleeding episodes in ...
The FDA has approved a new fibrinogen concentrate — fibrinogen, human-chmt (Fesilty, Grifols Therapeutics, LLC) — for the treatment of acute bleeding episodes in pediatric and adult patients with ...
PARAMUS, N.J., Jan. 7, 2026 /PRNewswire/ -- Octapharma USA, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new 2-gram presentation of Fibryga®, Fibrinogen (Human) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results